President Jair Bolsonaro recently made several appointments to the Board of Commissioners at ANVISA (Brazil's equivalent to the US FDA), a group commonly referred to in Portuguese as 'DICOL.' President Bolsonaro's appointment of three Deputy Commissioners – Cristiane Rose Jourdan Gomes, Alex Machado Campos, and Meiruze Sousa Freitas (who has been occupying the position on a provisional basis since April 2020) – was formalized through publication in the Official Gazette on November 4th and 5th. The appointment of Antônio Barra Torres as the Commissioner of ANVISA, a position he has occupied provisionally since December 2019, was also officially recognized.
The new Commissioner and Deputy Commissioners will share DICOL with Deputy Commissioner Alessandra Bastos until her term ends on December 19th. As her replacement, President Bolsonaro has submitted the nomination of Colonel Jorge Luiz Kormann for the Senate's consideration. Presidential appointments to DICOL must receive Senate approval as a checks-and-balance mechanism. Once approved by the Senate, Kormann's appointment to DICOL will be confirmed and published in the Official Gazette.
Following the publication of the appointments in the Official Gazette, ANVISA designated the new Deputy Commissioners to their respective offices (as set by ANVISA's Rule #439/2020). The Licks' team has prepared a background summary for each commissioner:
For more information on these appointments, please contact us at email@example.com.